B
Bruce Neal
Researcher at The George Institute for Global Health
Publications - 620
Citations - 109123
Bruce Neal is an academic researcher from The George Institute for Global Health. The author has contributed to research in topics: Population & Blood pressure. The author has an hindex of 108, co-authored 561 publications receiving 87213 citations. Previous affiliations of Bruce Neal include National Institutes of Health & University of the Western Cape.
Papers
More filters
Journal ArticleDOI
Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis
Milad Nazarzadeh,Zeinab Bidel,Dexter Canoy,Emma Copland,Derrick A Bennett,Abbas Dehghan,George Davey Smith,Rury R. Holman,Mark Woodward,Ajay Gupta,Amanda I Adler,Malgorzata Wamil,Naveed Sattar,William C. Cushman,Richard J McManus,K. Teo,Barry R. Davis,John Chalmers,Carl J. Pepine,Kazem Rahimi,Lawrence Y. Agodoa,Ale Algra,Folkert W. Asselbergs,N Beckett,Eivind Berge,Henry R. Black,Frank P. Brouwers,M. Brown,Christopher J. Bulpitt,Bob Byington,J E Cutler,Richard B. Devereux,John Dwyer,Raymond O. Estacio,R. H. Fagard,K K Fox,Takeshi Fukui,Yutaka Imai,Misaki Ishii,Stevo Julius,Yoshihiko Kanno,S.E. Kjeldsen,John B. Kostis,K. Kuramoto,Jan Lanke,Edmund J. Lewis,J. Lewis,M. Lievre,Lars H Lindholm,Stephan Lueders,Stephen MacMahon,Giuseppe Mancia,M. Matsuzaki,Maria H Mehlum,S. Nissen,Hisao Ogawa,Tsutomu Ogihara,Tomihiko Ohkubo,C. Palmer,Anushka Patel,Melanie Pfeffer,Neil R Poulter,Hiromi Rakugi,Gianpaolo Reboldi,Christopher M. Reid,Giuseppe Remuzzi,Piero Ruggenenti,Toshihisa Saruta,J Schrader,Robert W. Schrier,Peter S. Sever,Peter Sleight,Jan A. Staessen,Hiromichi Suzuki,L. Thijs,Kazuaki Ueshima,Seiji Umemoto,Wiek H. van Gilst,Paolo Verdecchia,Kristian Wachtell,Paul K. Whelton,Lindon M H Wing,Yoshida Yui,SM Taslim Yusuf,Alberto Zanchetti,Z. Zhang,C. Anderson,Colin Baigent,B. Brenner,R Collins,Dick de Zeeuw,Jacobus Lubsen,Ettore Malacco,Bruce Neal,Vlado Perkovic,Brendan Pitt,Anthony Rodgers,Peter M. Rothwell,Gholamreza Salimi-Khorshidi,Jessica Sundström,Fiona Turnbull,Giancarlo Viberti,J. Wang +102 more
Journal ArticleDOI
Rationale, design, and baseline characteristics of the Salt Substitute in India Study (SSiIS): The protocol for a double-blinded, randomized-controlled trial.
Sudhir Raj Thout,Jie Yu,Jie Yu,Maoyi Tian,Mark D. Huffman,Mark D. Huffman,Clare Arnott,Clare Arnott,Clare Arnott,Qiang Li,Praveen Devarsetty,Claire Johnson,Simone Pettigrew,Bruce Neal,Bruce Neal,Jason H Y Wu +15 more
TL;DR: Baseline findings suggest sodium intake in this population significantly exceeds World Health Organization recommendations, and is well placed to determine whether salt substitution is an effective means of lowering blood pressure for rural Indian patients with hypertension.
Journal ArticleDOI
Effects of the vasopeptidase inhibitor, omapatrilat, in 723 patients with coronary heart disease.
TL;DR: Omapatrilat produced changes in BP, neurohormone and biochemical parameters that were similar for the two doses, and a large-scale randomised trial would be required to reliably establish the effects of omap atrilat on the risks of major vascular disease events among patients with coronary heart disease.
Journal ArticleDOI
Salt intake and iodine status of women in Samoa
Mary-Anne Land,Jacqui Webster,Gary Ma,Mu Li,Sarah Asi Faletoese Su'a,Merina Ieremia,Satu Viali,Gavin Faeamani,A. Colin Bell,Christine Quested,Bruce Neal,Creswell J Eastman +11 more
TL;DR: Iodine nutrition appears to be insufficient in this population and may be indicative of iodine deficiency disorders in Samoan women, and a collaborative approach in monitoring iodine status and salt intake will strengthen both programs and greatly inform the level of iodine fortification required to ensure optimal iodine intake as population salt reduction programs take effect.
Journal ArticleDOI
Homeostasis model assessment of insulin resistance and survival in patients with diabetes and acute coronary syndrome
Barbara E. Stähli,Barbara E. Stähli,Anna Nozza,Ilse C. Schrieks,John B. Buse,Klas Malmberg,Linda Mellbin,Bruce Neal,Stephen J. Nicholls,Lars Rydén,Anders Svensson,Hans Wedel,Arlette Weichert,A. Michael Lincoff,Diederick E. Grobbee,Jean-Claude Tardif,Gregory G. Schwartz +16 more
TL;DR: After accounting for levels of NT-proBNP, insulin resistance assessed by HOMA-IR is not related to the risk of death or major adverse cardiovascular events in patients with type 2 diabetes and ACS.